In vivo osteopontin-induced macrophage accumulation is dependent on CD44 expression

Cellular Immunology

Volumn 254, Issue 1, 2008, Pages 56-62

  Marcondes, Maria Cecilia G ^a   Poling, Matthew ^a   Watry, Debbie D ^a   Hall, DeShon ^a   Fox, Howard S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CD44; Chemotaxis; Macrophages; Osteopontin

Indexed keywords

ALPHA4 INTEGRIN; CHEMOATTRACTANT; HERMES ANTIGEN; OSTEOPONTIN; THROMBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL COUNT; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; GRANULOCYTE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD44; BLOTTING, WESTERN; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; OSTEOPONTIN;

ANIMALIA; MUS; RODENTIA;

EID: 55049109753     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2008.06.012     Document Type: Article

References (38)

1. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., Heller R., Oksenberg J.R., and Steinman L. The influence of the proinflammatory cytokine osteopontin on autoimmune demyelinating disease. Science 294 (2001) 1731-1735
2. Hur E.M., Youssef S., Haws M.E., Zhang S.Y., Sobel R.A., and Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8 (2007) 74-83
3. Jansson M., Panoutsakopoulou V., Baker J., Klein L., and Cantor H. Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. J. Immunol. 168 (2002) 2096-2099
4. Roberts E.S., Zandonatti M.A., Watry D.D., Madden L.J., Henriksen S.J., Taffe M.A., and Fox H.S. Induction of pathogenic sets of genes in macrophages and neurons in Neuro AIDS. Am. J. Pathol. 162 (2003) 2041-2057
5. Liaw L., Skinner M.P., Raines E.W., Ross R., Cheresh D.A., Schwartz S.M., and Giachelli C.M. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J. Clin. Invest. 95 (1995) 713-724
6. Weber G.F., Ashkar S., Glimcher M.J., and Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271 (1996) 509-512
7. Weber G.F., and Cantor H. The immunology of Eta-1/osteopontin. Cytokine Growth Factor Rev. 7 (1996) 241-248
8. Weber G.F., Zawaideh S., Hikita S., Kumar V.A., Cantor H., and Ashkar S. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J. Leukoc. Biol. 72 (2002) 752-761
9. Shinohara M.L., Lu L., Bu J., Werneck M.B., Kobayashi K.S., Glimcher L.H., and Cantor H. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat. Immunol. 7 (2006) 498-506
10. Kawamura K., Iyonaga K., Ichiyasu H., Nagano J., Suga M., and Sasaki Y. Differentiation, maturation, and survival of dendritic cells by osteopontin regulation. Clin. Diagn. Lab. Immunol. 12 (2005) 206-212
11. Katagiri Y.U., Sleeman J., Fujii H., Herrlich P., Hotta H., Tanaka K., Chikuma S., Yagita H., Okumura K., Murakami M., Saiki I., Chambers A.F., and Uede T. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 59 (1999) 219-226
12. Nasu K., Ishida T., Setoguchi M., Higuchi Y., Akizuki S., and Yamamoto S. Expression of wild-type and mutated rabbit osteopontin in Escherichia coli and their effects on adhesion and migration of P388D1 cells. Biochem. J. 307 Pt 1 (1995) 257-265
13. Denda S., Reichardt L.F., and Muller U. Identification of osteopontin as a novel ligand for the integrin alpha8 beta1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol. Biol. Cell 9 (1998) 1425-1435
14. Hu D.D., Lin E.C., Kovach N.L., Hoyer J.R., and Smith J.W. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J. Biol. Chem. 270 (1995) 26232-26238
15. Miyauchi A., Alvarez J., Greenfield E.M., Teti A., Grano M., Colucci S., Zambonin-Zallone A., Ross F.P., Teitelbaum S.L., Cheresh D., et al. Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. J. Biol. Chem. 266 (1991) 20369-20374
16. Yokosaki Y., Matsuura N., Sasaki T., Murakami I., Schneider H., Higashiyama S., Saitoh Y., Yamakido M., Taooka Y., and Sheppard D. The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J. Biol. Chem. 274 (1999) 36328-36334
17. Bayless K.J., Meininger G.A., Scholtz J.M., and Davis G.E. Osteopontin is a ligand for the alpha4beta1 integrin. J. Cell Sci. 111 Pt 9 (1998) 1165-1174
18. Johnson J.D., Hess K.L., and Cook-Mills J.M. CD44, alpha(4) integrin, and fucoidin receptor-mediated phagocytosis of apoptotic leukocytes. J. Leukoc. Biol. 74 (2003) 810-820
19. Braumuller H., Gansauge S., Ramadani M., and Gansauge F. CD44v6 cell surface expression is a common feature of macrophages and macrophage-like cells-implication for a natural macrophage extravasation mechanism mimicked by tumor cells. FEBS Lett. 476 (2000) 240-247
20. Marroquin C.E., Downey L., Guo H., and Kuo P.C. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells. Immunol. Lett. 95 (2004) 109-112
21. Mytar B., Baran J., Gawlicka M., Ruggiero I., and Zembala M. Immunophenotypic changes and induction of apoptosis of monocytes and tumour cells during their interactions in vitro. Anticancer Res. 22 (2002) 2789-2796
22. Marcondes M.C., Burdo T.H., Watry D.D., and Fox H.S. Increased CD44v6 expression levels on monocytes precede the development of encephalitis in SIV-infected rhesus macaques. J. Infect. Dis. 197 (2008) 1567-1576
23. Wiley C.A., Schrier R.D., Nelson J.A., Lampert P.W., and Oldstone M.B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83 (1986) 7089-7093
24. Burdo T.H., Wood M.R., and Fox H.S. Osteopontin prevents monocyte recirculation and apoptosis. J. Leukoc. Biol. 81 (2007) 1504-1511
25. Gauer S., Hauser I.A., Obermuller N., Holzmann Y., Geiger H., and Goppelt-Struebe M. Synergistic induction of osteopontin by aldosterone and inflammatory cytokines in mesangial cells. J. Cell. Biochem. 103 (2008) 615-623
26. Weiss J.M., Renkl A.C., Maier C.S., Kimmig M., Liaw L., Ahrens T., Kon S., Maeda M., Hotta H., Uede T., and Simon J.C. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing langerhans and dendritic cell migration to lymph nodes. J. Exp. Med. 194 (2001) 1219-1229
27. Schmits R., Filmus J., Gerwin N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J., Furlonger C., Zakarian A., Simard J.J., Ohashi P.S., Paige C.J., Gutierrez-Ramos J.C., and Mak T.W. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90 (1997) 2217-2233
28. Rittling S.R., Matsumoto H.N., McKee M.D., Nanci A., An X.R., Novick K.E., Kowalski A.J., Noda M., and Denhardt D.T. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 13 (1998) 1101-1111
29. Yamamoto N., Sakai F., Kon S., Morimoto J., Kimura C., Yamazaki H., Okazaki I., Seki N., Fujii T., and Uede T. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J. Clin. Invest. 112 (2003) 181-188
30. Chen L., Wu W., Dentchev T., Zeng Y., Wang J., Tsui I., Tobias J.W., Bennett J., Baldwin D., and Dunaief J.L. Light damage induced changes in mouse retinal gene expression. Exp. Eye Res. 79 (2004) 239-247
31. Katoh S., Matsubara Y., Taniguchi H., Fukushima K., Mukae H., Kadota J., Matsukura S., and Kohno S. Characterization of CD44 expressed on alveolar macrophages in patients with diffuse panbronchiolitis. Clin. Exp. Immunol. 126 (2001) 545-550
32. Sano N., Kitazawa K., and Sugisaki T. Localization and roles of CD44, hyaluronic acid and osteopontin in IgA nephropathy. Nephron 89 (2001) 416-421
33. Nystrom T., Duner P., and Hultgardh-Nilsson A. A constitutive endogenous osteopontin production is important for macrophage function and differentiation. Exp. Cell Res. 313 (2007) 1149-1160
34. Giachelli C.M., Lombardi D., Johnson R.J., Murry C.E., and Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am. J. Pathol. 152 (1998) 353-358
35. Nomiyama T., Perez-Tilve D., Ogawa D., Gizard F., Zhao Y., Heywood E.B., Jones K.L., Kawamori R., Cassis L.A., Tschop M.H., and Bruemmer D. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J. Clin. Invest. 117 (2007) 2877-2888
36. Tanaka K., Morimoto J., Kon S., Kimura C., Inobe M., Diao H., Hirschfeld G., Weiss J.M., and Uede T. Effect of osteopontin alleles on beta-glucan-induced granuloma formation in the mouse liver. Am. J. Pathol. 164 (2004) 567-575
37. Zhu B., Suzuki K., Goldberg H.A., Rittling S.R., Denhardt D.T., McCulloch C.A., and Sodek J. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J. Cell. Physiol. 198 (2004) 155-167
38. Konno S., Hoshi T., Taira T., Plunkett B., and Huang S.K. Endotoxin contamination contributes to the in vitro cytokine-inducing activity of osteopontin preparations. J. Interferon Cytokine Res. 25 (2005) 277-282